GeoWealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.86M Buy
38,770
+12,234
+46% +$526K 0.06% 189
2026
Q1
$975K Buy
26,536
+3,562
+16% +$169K 0.04% 294
2025
Q4
$1.17M Buy
22,974
+6,190
+37% +$317K 0.04% 241
2025
Q3
$931K Buy
16,784
+1,592
+10% +$93.2K 0.03% 313
2025
Q2
$1.05M Buy
15,192
+4,575
+43% +$311K 0.04% 242
2025
Q1
$737K Sell
10,617
-5,518
-34% -$456K 0.03% 339
2024
Q4
$1.39M Buy
16,135
+1,168
+8% +$126K 0.05% 236
2024
Q3
$1.78M Sell
14,967
-6,040
-29% -$806K 0.06% 201
2024
Q2
$3M Buy
21,007
+6,298
+43% +$835K 0.13% 117
2024
Q1
$1.89M Buy
14,709
+1,214
+9% +$145K 0.07% 181
2023
Q4
$1.4M Buy
13,495
+13,207
+4,586% +$1.31M 0.12% 175
2023
Q3
$26K Buy
288
+142
+97% +$12.5K ﹤0.01% 426
2023
Q2
$12K Buy
+146
New +$11.9K ﹤0.01% 401

Other funds holding NVO

GeoWealth Management's NVO Position: Q2 2026 in Review

GeoWealth Management increased its Novo Nordisk (NVO) stake by 46% in Q2 2026, buying an estimated $526K and bringing the position to 38,770 shares worth $1.86M. The position accounts for 0.06% of the portfolio, ranked #189.

GeoWealth Management first reported a position in NVO in Q2 2023 and has held it in 13 quarters since. The position peaked at $3M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • GeoWealth Management held 38,770 shares of Novo Nordisk worth $1.86M as of Q2 2026.
  • GeoWealth Management bought 12,234 Novo Nordisk shares in Q2 2026, an estimated $526K.
  • Novo Nordisk made up 0.06% of GeoWealth Management's portfolio in Q2 2026, its #189 holding.
  • GeoWealth Management first reported a position in Novo Nordisk in Q2 2023 and has held it in 13 quarters since.
  • GeoWealth Management's Novo Nordisk position peaked at $3M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on GeoWealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.